DEFA14A: Avanos Medical, Inc. Sets Date for 2024 Annual Meeting, Proxy Materials Available

Avanos Medical, Inc. announces its 2024 Annual Meeting of Stockholders to be held on April 25, 2024, and provides information on accessing proxy materials and voting.

Summary

• Avanos Medical, Inc. is holding its 2024 Annual Meeting of Stockholders on April 25, 2024.
• Stockholders can vote on proposals including the election of directors, ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for 2024, and an advisory vote on executive compensation.
• Proxy materials are available online or can be requested in paper or email format prior to April 11, 2024.
• The meeting will be held at 5405 Windward Parkway, Alpharetta, GA 30004 at 9:00 a.m. Eastern Time.

Sentiment

Score: 5

Explanation: The document is a neutral announcement regarding the annual meeting and proxy voting, with no inherent positive or negative sentiment.

Positives

• Stockholders have multiple options for accessing proxy materials and voting, including online, by phone, and in person.
• The company provides clear instructions on how to obtain proxy materials and vote.

Future Outlook

The document outlines the process for the upcoming annual meeting and provides no specific forward-looking statements about the company's financial performance or strategic direction.

Industry Context

This is a standard proxy statement related to an annual meeting, a routine part of corporate governance for publicly traded companies.

Stakeholder Impact

• Shareholders are encouraged to participate in the voting process to influence the company's direction.
• The outcome of the votes will impact the composition of the board of directors and the selection of the company's auditor.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals.
• The company will hold its Annual Meeting on April 25, 2024.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Stockholders, Voting, Avanos Medical, Directors, Deloitte & Touche, Executive Compensation